These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Rudrabhatla PK; Reghukumar A; Thomas SV Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787 [TBL] [Abstract][Full Text] [Related]
5. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease. Rao C; R M J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509 [TBL] [Abstract][Full Text] [Related]
6. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. García-Carnero LC; Mora-Montes HM J Fungi (Basel); 2022 Apr; 8(5):. PubMed ID: 35628701 [TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series. Singh Y; Ganesh V; Kumar S; Patel N; Aggarwala R; Soni KD; Trikha A Cureus; 2021 Jul; 13(7):e16152. PubMed ID: 34354889 [TBL] [Abstract][Full Text] [Related]
8. Massive hemoptysis causing mortality in a post COVID-19 infected Asian male patient: Presenting as pulmonary mucormycosis, pulmonary tuberculosis and later sino-nasal mucormycosis. Rana G; Gautam S; Mawari G; Daga MK; Kumar N; Raghu RV Respir Med Case Rep; 2021; 34():101511. PubMed ID: 34513586 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India. Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 and mucormycosis superinfection: the perfect storm. Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291 [TBL] [Abstract][Full Text] [Related]
11. Mass urine sugar testing to tackle post-COVID mucormycosis epidemic in India-MUSTARD concept. Garg P; Mittal S Diabetes Metab Syndr; 2021; 15(4):102177. PubMed ID: 34198108 [TBL] [Abstract][Full Text] [Related]
12. New insights on mucormycosis and its association with the COVID-19 pandemic. Alshahawey MG; El-Housseiny GS; Elsayed NS; Alshahrani MY; Wakeel LM; Aboshanab KM Future Sci OA; 2022 Feb; 8(2):FSO772. PubMed ID: 35059222 [TBL] [Abstract][Full Text] [Related]
13. New-onset hyperglycaemia and prolonged systemic corticosteroids therapy in mild COVID-19 patients as major risk factors for invasive mucormycosis: a preliminary study. Khichar S; Samantaray S; Kumar D; Mobarsa V; Jain V; Sharma V; Soni K; Choudhury B; Goyal A; Shankar Meena D; Srinivasan S; Dutt N; Bhardwaj P; Agarwal A; Kumar Garg M; Misra S Curr Med Mycol; 2021 Sep; 7(3):22-28. PubMed ID: 35528622 [TBL] [Abstract][Full Text] [Related]
14. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach. Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920 [TBL] [Abstract][Full Text] [Related]
15. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Ahmadikia K; Hashemi SJ; Khodavaisy S; Getso MI; Alijani N; Badali H; Mirhendi H; Salehi M; Tabari A; Mohammadi Ardehali M; Kord M; Roilides E; Rezaie S Mycoses; 2021 Aug; 64(8):798-808. PubMed ID: 33590551 [TBL] [Abstract][Full Text] [Related]
16. Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics. Gupta G; S R; Singh Y; Thangavelu L; Singh SK; Dureja H; Chellappan DK; Dua K Drug Dev Res; 2021 Nov; 82(7):880-882. PubMed ID: 34323298 [TBL] [Abstract][Full Text] [Related]
17. Mucormycosis and COVID-19: An epidemic within a pandemic in India. Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907 [TBL] [Abstract][Full Text] [Related]
18. The Mystery of Mucormycosis in COVID-19: A Multifactorial Menace or an Enigmatic Delta Variant Associated Phenomenon? An Exploratory Study from a Tertiary Care Centre in North India with a Brief Literature Review. Kalita D; Bhatia M; Rekha US; Singh A J Pharm Bioallied Sci; 2022; 14(1):46-51. PubMed ID: 35784107 [TBL] [Abstract][Full Text] [Related]
19. Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario. Bhardwaj R; Sharma A; Parasher A; Gupta H; Sahu S; Pal S Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3492-3497. PubMed ID: 34786356 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India. Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]